Enhanced CD40 Signaling Drives B10 Cell Expansion in Mice
Author Information
Author(s): Poe Jonathan C., Smith Susan H., Haas Karen M., Yanaba Koichi, Tsubata Takeshi, Matsushita Takashi, Tedder Thomas F.
Primary Institution: Duke University Medical Center
Hypothesis
The combination of CD154 expression and CD22 deficiency in mice will enhance B cell CD40 signaling and lead to autoimmune disease due to autoreactive B cell expansion.
Conclusion
The study demonstrates that the IL-10-producing B10 B cell subset can suppress IgG immune responses against both foreign and self antigens.
Supporting Evidence
- CD154TGCD22−/− mice showed a 16-fold expansion of functional, mature IL-10-competent regulatory spleen B cells.
- Despite an expanded spleen B cell pool, CD154TGCD22−/− mice generated minimal IgG responses.
- Therapeutic agents that drive regulatory B10 cell expansion may inhibit pathogenic IgG autoantibody production.
Takeaway
Mice with enhanced CD40 signaling produced more regulatory B10 cells, which helped keep their immune responses in check, preventing excessive antibody production.
Methodology
The study involved generating CD154TGCD22−/− mice and assessing their immune responses and lymphocyte subsets.
Participant Demographics
Mice used were between 8 and 14 weeks of age.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website